Triple agonist UBT251 delivers up to 19.7%
UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed…
The European Commission approves more
The European Commission has granted final approval of a higher 7.2 mg maintenance dose of Wegovy® (semaglutide) for…
The European Commission approves more
The European Commission has granted final approval of a higher 7.2 mg maintenance dose of Wegovy® (semaglutide) for…